Higher plasma tau levels have been reported in MM compared to VV and MV carriers [11,44,45], and prior studies using the Quanterix tau assay observed an interaction between the PRNP genotype and plasma tau levels and survival time [45,46,47]. The gene discussed is MAPT; the disease is Miyoshi myopathy.